chr1-43920773-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006279.5(ST3GAL3):​c.892-9G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0579 in 1,614,058 control chromosomes in the GnomAD database, including 3,083 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 211 hom., cov: 32)
Exomes 𝑓: 0.059 ( 2872 hom. )

Consequence

ST3GAL3
NM_006279.5 intron

Scores

2
Splicing: ADA: 0.0001221
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.45

Publications

3 publications found
Variant links:
Genes affected
ST3GAL3 (HGNC:10866): (ST3 beta-galactoside alpha-2,3-sialyltransferase 3) The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The encoded protein is normally found in the Golgi apparatus but can be proteolytically processed to a soluble form. This protein is a member of glycosyltransferase family 29. Mutations in this gene have been associated with a form of autosomal recessive nonsymdromic cognitive disability as well as infantile epileptic encephalopathy. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
ST3GAL3 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 15
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • intellectual disability, autosomal recessive 12
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-43920773-G-A is Benign according to our data. Variant chr1-43920773-G-A is described in ClinVar as [Benign]. Clinvar id is 130375.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0652 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ST3GAL3NM_006279.5 linkc.892-9G>A intron_variant Intron 10 of 11 ENST00000347631.8 NP_006270.1 Q11203-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ST3GAL3ENST00000347631.8 linkc.892-9G>A intron_variant Intron 10 of 11 5 NM_006279.5 ENSP00000317192.6 Q11203-1
ENSG00000284989ENST00000645057.1 linkn.*2214-9G>A intron_variant Intron 24 of 25 ENSP00000494063.1 A0A2R8Y4U1

Frequencies

GnomAD3 genomes
AF:
0.0434
AC:
6605
AN:
152090
Hom.:
209
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0125
Gnomad AMI
AF:
0.0450
Gnomad AMR
AF:
0.0310
Gnomad ASJ
AF:
0.0254
Gnomad EAS
AF:
0.000771
Gnomad SAS
AF:
0.0323
Gnomad FIN
AF:
0.0672
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0668
Gnomad OTH
AF:
0.0320
GnomAD2 exomes
AF:
0.0457
AC:
11465
AN:
251112
AF XY:
0.0466
show subpopulations
Gnomad AFR exome
AF:
0.0130
Gnomad AMR exome
AF:
0.0336
Gnomad ASJ exome
AF:
0.0287
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.0622
Gnomad NFE exome
AF:
0.0632
Gnomad OTH exome
AF:
0.0505
GnomAD4 exome
AF:
0.0595
AC:
86915
AN:
1461850
Hom.:
2872
Cov.:
37
AF XY:
0.0588
AC XY:
42765
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.0102
AC:
340
AN:
33480
American (AMR)
AF:
0.0328
AC:
1469
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0283
AC:
739
AN:
26136
East Asian (EAS)
AF:
0.000504
AC:
20
AN:
39700
South Asian (SAS)
AF:
0.0350
AC:
3020
AN:
86256
European-Finnish (FIN)
AF:
0.0626
AC:
3344
AN:
53414
Middle Eastern (MID)
AF:
0.0192
AC:
111
AN:
5768
European-Non Finnish (NFE)
AF:
0.0672
AC:
74679
AN:
1111980
Other (OTH)
AF:
0.0529
AC:
3193
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
5042
10084
15127
20169
25211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2692
5384
8076
10768
13460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0435
AC:
6614
AN:
152208
Hom.:
211
Cov.:
32
AF XY:
0.0423
AC XY:
3150
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.0125
AC:
519
AN:
41530
American (AMR)
AF:
0.0313
AC:
479
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0254
AC:
88
AN:
3470
East Asian (EAS)
AF:
0.000773
AC:
4
AN:
5176
South Asian (SAS)
AF:
0.0329
AC:
159
AN:
4826
European-Finnish (FIN)
AF:
0.0672
AC:
712
AN:
10598
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0668
AC:
4542
AN:
67996
Other (OTH)
AF:
0.0317
AC:
67
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
336
672
1007
1343
1679
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0560
Hom.:
160
Bravo
AF:
0.0388
Asia WGS
AF:
0.0160
AC:
55
AN:
3478
EpiCase
AF:
0.0574
EpiControl
AF:
0.0573

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Jun 14, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Sep 04, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Developmental and epileptic encephalopathy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.13
DANN
Benign
0.69
PhyloP100
-1.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00012
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80055718; hg19: chr1-44386445; COSMIC: COSV53512497; COSMIC: COSV53512497; API